These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15652390)

  • 1. Effects of the cannabinoid receptor agonist WIN 55,212-2 on operant behavior and locomotor activity in rats.
    Drews E; Schneider M; Koch M
    Pharmacol Biochem Behav; 2005 Jan; 80(1):145-50. PubMed ID: 15652390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-lasting increase of alcohol relapse by the cannabinoid receptor agonist WIN 55,212-2 during alcohol deprivation.
    López-Moreno JA; González-Cuevas G; Rodríguez de Fonseca F; Navarro M
    J Neurosci; 2004 Sep; 24(38):8245-52. PubMed ID: 15385608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased sensitivity of adolescent spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder, to the locomotor stimulation induced by the cannabinoid receptor agonist WIN 55,212-2.
    Pandolfo P; Pamplona FA; Prediger RD; Takahashi RN
    Eur J Pharmacol; 2007 Jun; 563(1-3):141-8. PubMed ID: 17374533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats.
    Schneider M; Koch M
    Neuropsychopharmacology; 2003 Oct; 28(10):1760-9. PubMed ID: 12888772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid-induced conditioned place preference in the spontaneously hypertensive rat-an animal model of attention deficit hyperactivity disorder.
    Pandolfo P; Vendruscolo LF; Sordi R; Takahashi RN
    Psychopharmacology (Berl); 2009 Aug; 205(2):319-26. PubMed ID: 19407992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frustrative nonreward and cannabinoid receptors: Chronic (but not acute) WIN 55,212-2 treatment increased resistance to change in two reward downshift tasks.
    Conrad SE; Davis D; Vilcek N; Thompson JB; Guarino S; Papini S; Papini MR
    Pharmacol Biochem Behav; 2022 Feb; 213():173320. PubMed ID: 34990705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats.
    Chaperon F; Soubrié P; Puech AJ; Thiébot MH
    Psychopharmacology (Berl); 1998 Feb; 135(4):324-32. PubMed ID: 9539255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of kappa/dynorphin system in WIN 55,212-2 self-administration in mice.
    Mendizábal V; Zimmer A; Maldonado R
    Neuropsychopharmacology; 2006 Sep; 31(9):1957-66. PubMed ID: 16292318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55,212-2.
    Schneider M; Drews E; Koch M
    Behav Pharmacol; 2005 Sep; 16(5-6):447-54. PubMed ID: 16148450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial agonist-like profile of the cannabinoid receptor antagonist SR141716A in a food-reinforced operant paradigm.
    De Vry J; Jentzsch KR
    Behav Pharmacol; 2004 Feb; 15(1):13-20. PubMed ID: 15075622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of paraoxon toxicity by the cannabinoid receptor agonist WIN 55,212-2.
    Nallapaneni A; Liu J; Karanth S; Pope C
    Toxicology; 2006 Oct; 227(1-2):173-83. PubMed ID: 16956707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cannabinoid agonist WIN 55,212-2 reduces sensorimotor gating and recognition memory in rats.
    Schneider M; Koch M
    Behav Pharmacol; 2002 Feb; 13(1):29-37. PubMed ID: 11990717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
    Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M
    Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid receptor-independent actions of the aminoalkylindole WIN 55,212-2 on trigeminal sensory neurons.
    Price TJ; Patwardhan A; Akopian AN; Hargreaves KM; Flores CM
    Br J Pharmacol; 2004 May; 142(2):257-66. PubMed ID: 15155534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.
    Gamaleddin I; Wertheim C; Zhu AZ; Coen KM; Vemuri K; Makryannis A; Goldberg SR; Le Foll B
    Addict Biol; 2012 Jan; 17(1):47-61. PubMed ID: 21521420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WIN 55,212-2 decreases the reinforcing actions of cocaine through CB1 cannabinoid receptor stimulation.
    Vlachou S; Nomikos GG; Panagis G
    Behav Brain Res; 2003 May; 141(2):215-22. PubMed ID: 12742258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development.
    De Vry J; Jentzsch KR; Kuhl E; Eckel G
    Behav Pharmacol; 2004 Feb; 15(1):1-12. PubMed ID: 15075621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basolateral amygdala CB1 cannabinoid receptors mediate nicotine-induced place preference.
    Hashemizadeh S; Sardari M; Rezayof A
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():65-71. PubMed ID: 24468643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats.
    Fattore L; Cossu G; Martellotta CM; Fratta W
    Psychopharmacology (Berl); 2001 Aug; 156(4):410-6. PubMed ID: 11498718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
    Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
    Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.